Evidence map›Paper›PMID 39402369›Full record

ArticleActa neurochirurgica2024

Growth dynamics of Rathke's Cleft cyst: a risk score system for surgical decision making.

Mohammad Bilal Alsavaf, Jaskaran S Gosal, Kyle C Wu, Shoban Babu Varthya, Moataz D Abouammo, Luciano M Prevedello, Ricardo L Carrau, Daniel M Prevedello

Abstract read
In one paragraph

Article in Acta neurochirurgica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Data-Driven Approach for Rathke's Cleft Cysts Management.Diagnostics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad Bilal AlsavafDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, 410 W 10Th Ave, Columbus, Ohio, 43210-1228, USA.
Jaskaran S GosalDepartment of Neurological Surgery, The Ohio State University Wexner Medical Center, 410 W 10Th Ave, Columbus, Ohio, 43210-1228, USA.
Kyle C WuDepartment of Neurological Surgery, The Ohio State University Wexner Medical Center, 410 W 10Th Ave, Columbus, Ohio, 43210-1228, USA.
Shoban Babu VarthyaDepartment of Pharmacology, AIIMS Jodhpur, Jodhpur, India.
Moataz D AbouammoDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, 410 W 10Th Ave, Columbus, Ohio, 43210-1228, USA.
Luciano M PrevedelloDepartment of Neuroradiology, Wexner Medical Center at The Ohio State University, Columbus, OH, USA.
Ricardo L CarrauDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, 410 W 10Th Ave, Columbus, Ohio, 43210-1228, USA.
Daniel M PrevedelloDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, 410 W 10Th Ave, Columbus, Ohio, 43210-1228, USA. prev02@osumc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRathke's cleft cysts (RCCs) exhibit variable growth patterns, thus posing a challenge in predicting progression. While some RCCs may not cause symptoms, others can insidiously cause pituitary dysfunction, which is often irreversible, even following surgery. Hence, it is crucial to identify asymptomatic RCCs that grow rapidly and pose a higher risk of causing endocrinologic dysfunction. This enables timely surgical intervention to prevent permanent damage. Our study examines the growth rate of RCCs, identifies factors that accelerate growth, and discusses the clinical implications of these findings.

methodsA retrospective analysis of a prospectively maintained electronic database revealed 45 patients aged 18-80 years who underwent endoscopic endonasal surgery (EEA) for RCCs between 2010 and 2022 at our center. Of these, 20 required early operative intervention. The remaining 25 patients were followed closely clinically and radiologically before requiring surgery (initial conservative management group). We conducted an analysis of the factors predicting growth over time in this group. Using a regression model, we constructed a risk score system to predict RCC growth over time.

resultsPatients in the initial conservative group had smaller cysts and were generally older than those in the early surgery group. Patients with preoperative pituitary dysfunction showed a higher median growth of 1.0 mm in the longest diameter compared to those with normal pituitary function, with an increase of 0.5 mm. A sum of annual cyst growth of all (z, y, x) diameters, at a rate of 3 mm or greater, was associated with a clinically significant increase in the risk of pituitary dysfunction, exceeding 50%.The most significant factors predicting rapid growth in RCCs were smoking status, age, and T1-weighted magnetic resonance imaging (MRI) intensity of cysts. Smoking was the most critical risk factor for rapid cyst growth (p =  < .001). Our risk score system accurately predicted RCC growth with a 74% accuracy rate, 73% sensitivity, and 75% specificity.

conclusionOur analysis showed a strong link between active smoking and the rapid growth of RCC. This novel finding has significant preventive implications but needs validation by a large population database. Surgical intervention for RCC currently is often reserved for symptomatic cases. However, utilizing our risk-based scoring system to predict rapidly growing cysts may indicate early surgery in minimally symptomatic patients, thereby potentially preserving pituitary function.

Indexed as

Central Nervous System CystsAdolescentAdultAgedAged, 80 and overClinical Decision-MakingDisease ProgressionFemaleHumansMaleMiddle AgedPituitary NeoplasmsRetrospective StudiesRisk AssessmentRisk FactorsYoung AdultCerebrospinal fluid leakEarly surgeryEndoscopic endonasal approachGrowth rateImagingPituitary dysfunctionPituitary functionPredictive modelPrognosisRathke cleft cystRisk scoreSkull baseSmoking

Identifiers

PMID39402369
PMCPMC11473570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.